>北美药物-设备组合市场，按产品（自动注射器、微针贴片、数字药丸、智能吸入器、药物输送水凝胶、药物洗脱镜片等）、应用类型（骨科疾病、呼吸系统疾病、糖尿病肿瘤学心血管疾病等）、最终用户（诊所、医院、家庭护理环境、门诊护理中心等）、分销渠道（直接招标、零售销售等）、国家（美国、加拿大、墨西哥）行业趋势和预测到 2028 年。
市场分析与洞察：北美药械组合市场
预计药械组合市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 10.9%，预计将从 2020 年的 80.8679 亿美元达到 2028 年的 178.4353 亿美元。药械组合产品的使用量增加、COVID-19 发病率上升是预测期内推动市场需求的主要驱动力。
慢性病的日益流行以及技术的进步有效地促进了药物-器械组合市场的增长。然而，药物-器械组合的局限性和复杂性可能会阻碍医疗器械市场的未来发展。重要市场参与者的伙伴关系和合作为全球药物-器械组合市场的增长提供了机会。
药物-器械组合市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
北美药械组合市场范围和市场规模
药物-器械组合市场根据产品、应用、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品，药械组合市场细分为自动注射器、微针贴片、数字药丸、智能吸入器、药物输送水凝胶、药物洗脱镜片等。自动注射器进一步细分为可穿戴自动注射器、手持式自动注射器。2021 年，由于大量患者患有慢性疾病，自动注射器在药械组合市场中占有最高份额。
- 根据应用，全球药械组合市场细分为骨科疾病、呼吸系统疾病、糖尿病、肿瘤科、心血管疾病等。2021 年，由于手术数量不断增加，预计骨科将主导药械组合市场。此外，政府的一项举措预计将推动市场进一步增长。
- 根据最终用户，药械组合市场细分为诊所、医院、家庭护理机构、门诊护理中心等。预计 2021 年诊所将主导药械组合市场，因为大多数患者都患有慢性疾病，因此他们会去诊所接受适当的定期检查、治疗和管理。此外，由于 COVID-19，大多数患者不愿意去医院，因为害怕感染。
- 根据分销渠道，药械组合市场分为直接招标、零售销售和其他。2021 年，直接招标预计将主导药械组合市场，因为它可以完全控制销售和收入流程以及与客户的直接互动。由于发达国家和发展中国家的医院数量不断增加，该细分市场正在增长。
药械组合市场国家层面分析
分析了药物-器械组合市场，并按产品、应用类型、最终用户和分销渠道提供了市场规模信息。药物-器械组合市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于北美地区患者大量采用药物-器械组合产品，预计北美将主导市场。由于该地区主要市场参与者的存在感增加，美国在市场上占据主导地位并引领北美市场的增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
药械组合市场合作与伙伴关系的增多为药械组合市场参与者创造了新的机会
药物-器械组合市场还为您提供每个国家增长的详细市场分析。此外，它还提供有关主要市场参与者和初创公司之间的合作和伙伴关系的数据。此外，研发活动对药物-器械组合市场增长速度的影响越来越大。数据适用于 2010 年至 2019 年的历史时期
竞争格局和医疗器械市场份额分析
药物-器械组合市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对药物-器械组合市场的关注有关。
报告中涉及的主要参与者包括 Mediprint、OcuMedic、Medtronic、GlaxoSmithKline Plc、BD、Janssen Pharmaceuticals, Inc.（Johnson & Johnson Services, Inc. 的子公司）、Bayer AG、Micron Biomedical, Inc.、Otsuka America Pharmaceutical, Inc.、VAXXAS、Propeller Health、Raphas Co., Ltd.、EOFLOW CO., LTD.、Insulet Corporation、TheraJect、Zimmer Biomet、Amgen Inc.、Eitan Medical 以及其他国内和北美参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
主要参与者不断增长的合作、合同和协议加速了市场的增长。
例如，
- 2021 年 3 月，Eitan Medical 与 Stevanato 合作，将可穿戴注射解决方案推向市场，以简单高效的方式皮下注射大量高粘度药物，满足患者和制药公司的利益。这将加强全球领导力和创新能力。
- 4 月，EOFlow 有限公司美国子公司 Nephria 从德雷塞尔大学获得了新型“MXene”纳米材料的许可。Nephria 获得了独家权利，并计划从这项技术转让开始开发可穿戴透析系统，也称为可穿戴人工肾 (WAK)。这将加速新治疗领域的技术发展并促进市场增长。
- 2020年1月，安进公司宣布与百济神州成功达成战略合作，预计此次合作将在未来几年进一步增强该公司在中国肿瘤市场的影响力。
市场参与者的合作伙伴关系、合资企业和其他策略正在促进药品-设备组合市场的增长，这也有利于组织改进其产品以提供更好的消费者体验。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PATENT ANALYSIS
4.1.1 MANUFACTURING PROCESS OF COMBINATION PRODUCTS
4.1.2 APPROVAL BY AGENCY
4.1.3 PATENT GRANT
4.1.4 PATENT CERTIFICATIONS:
5 PIPELINE ANALYSIS
6 REGULATORY FRAMEWORKS:
6.1 U.S.
6.2 CANADA
7 REGIONAL SUMMARY
7.1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.1.1 OVERVIEW
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
8.1.2 GROWING GERIATRIC POPULATION
8.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES
8.1.4 RISING RATES OF OBESITY
8.2 RESTRAINTS
8.2.1 PRODUCT RECALLS
8.2.2 RISK ASSOCIATED WITH THE COMBINATION PRODUCTS
8.3 OPPORTUNITIES
8.3.1 RISING EXPENDITURE ON HEALTHCARE
8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
8.3.3 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES
8.3.4 INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
8.4 CHALLENGE
8.4.1 STRICT REGULATORY FRAMEWORK
9 IMPACT OF COVID-19 PANDEMIC ON THE NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON SUPPLY CHAIN
9.3 IMPACT ON DEMAND
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT
10.1 OVERVIEW
10.2 AUTO-INJECTOR
10.2.1 WEARABLE AUTO-INJECTOR
10.2.2 HAND HELD AUTO-INJECTOR
10.3 MICRONEEDLE PATCH
10.4 DIGITAL PILL
10.5 SMART INHALER
10.6 DRUG DELIVERY HYDROGELS
10.7 DRUG-ELUTING LENS
10.8 OTHERS
11 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ORTHOPEDIC DISEASES
11.3 RESPIRATORY DISEASES
11.4 DIABETES
11.5 ONCOLOGY
11.6 CARDIOVASCULAR DISEASES
11.7 OTHERS
12 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY END USER
12.1 OVERVIEW
12.2 CLINICS
12.3 HOSPITALS
12.4 HOME CARE SETTINGS
12.5 AMBULATORY CARE CENTERS
12.6 OTHERS
13 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAILS SALES
13.4 OTHERS
14 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY COUNTRY
14.1 OVERVIEW
14.2 NORTH AMERICA
14.2.1 U.S.
14.2.2 CANADA
14.2.3 MEXICO
15 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: COMPANY LANDSCAPE
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 AMGEN INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 GLAXOSMITHKLINE PLC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 MEDTRONIC
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 INSULET CORPORATION
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 BD
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENTS
17.7 BAYER AG
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 EITAN MEDICAL
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 EOFLOW CO., LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 MEDIPRINT
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 MICRON BIOMEDICAL, INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 OCUMEDIC
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 OTSUKA AMERICA PHARMACEUTICAL, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 PROPELLER HEALTH
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 RAPHAS CO., LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 SONCEBOZ
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 THERAJECT
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 VAXXAS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 ZIMMER BIOMET
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS
TABLE 2 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 7 U.S. DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 8 U.S. AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 9 U.S. DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 U.S. DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 11 U.S. DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 12 CANADA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 13 CANADA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 14 CANADA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 CANADA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 16 CANADA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 17 MEXICO DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 18 MEXICO AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 19 MEXICO DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 20 MEXICO DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 MEXICO DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: PRODUCT TYPE LIFELINE CURVE
FIGURE 8 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 13 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE NORTH AMERICA DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 THE AUTO-INJECTOR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DRUG-DEVICE COMBINATION MARKET IN THE YEAR 2021 & 2028
FIGURE 15 PORTER'S 5 FORCES
FIGURE 16 PESTEL'S MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
FIGURE 18 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 19 AGEING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 20 NORTH AMERICA AGEING POPULATION (IN MILLION)
FIGURE 21 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES, 2016
FIGURE 22 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2020
FIGURE 23 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 24 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 25 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 26 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2020
FIGURE 27 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 28 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 29 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, 2020
FIGURE 31 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 32 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 33 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 35 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 36 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 37 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 39 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 40 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT (2021-2028)
FIGURE 43 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
